Assessment of β-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography With Carbon 11–Labeled Pittsburgh Compound B

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

A New Clinical Scale for the Staging of Dementia

Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease

Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130

Phases of Aβ-deposition in the human brain and its relevance for the development of AD

Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490

PET imaging of amyloid deposition in patients with mild cognitive impairment

Forsberg, A., Engler, H., Almkvist, O., Blomquist, G., Hagman, G., Wall, A. E., Ringheim, A., Långström, B., & Nordberg, A. K. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.029 · Cited by 725

PET imaging of amyloid in Alzheimer's disease

Nordberg, A. K. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00853-1 · Cited by 462

Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees

Klunk, W. E., Price, J. C., Mathis, C. A., Tsopelas, N. D., Lopresti, B. J., Ziolko, S. K., Bi, W., Hoge, J. A., Cohen, A. D., Ikonomovic, M. D., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0730-07.2007 · Cited by 389

A total score for the CERAD neuropsychological battery

Chandler, M. J., Lacritz, L. H., Hynan, L. S., Barnard, H. D., Allen, G., Deschner, M., Weiner, M. F., & Cullum, C. M. (2005) · Neurology · doi:10.1212/01.wnl.0000167607.63000.38 · Cited by 387

Brain tissue Aβ42 levels are linked to shunt response in idiopathic normal pressure hydrocephalus

Hamdeh, S. A., Virhammar, J., Sehlin, D., Alafuzoff, I. I., Cesarini, K. G., & Marklund, N. (2018) · Journal of neurosurgery · doi:10.3171/2017.7.jns171005 · Cited by 41

Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease

Grand’Maison, M., Zehntner, S. P., Ho, M., Hébert, F., Wood, A., Carbonell, F., Zijdenbos, A. P., Hamel, É., & Bedell, B. J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.02.005 · Cited by 39

Amyloid-plaque imaging in early and differential diagnosis of dementia

Drzezga, A. E. (2010) · Annals of Nuclear Medicine · doi:10.1007/s12149-009-0330-9 · Cited by 37

Pittsburgh compound B and the postmortem diagnosis of alzheimer disease

Niedowicz, D. M., Beckett, T. L., Matveev, S., Weidner, A. M., Baig, I., Kryscio, R. J., Mendiondo, M. S., LeVine, H., Keller, J. N., & Murphy, M. P. (2012) · Annals of Neurology · doi:10.1002/ana.23633 · Cited by 37

APOE4 predicts amyloid-β in cortical brain biopsy but not idiopathic normal pressure hydrocephalus

Pyykkö, O. T., Helisalmi, S., Koivisto, A. M., Mölsä, J. A. A., Rummukainen, J. K., Nerg, O., Alafuzoff, I. I., Savolainen, S., Soininen, H. S., Jääskeläinen, J. E., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-303849 · Cited by 38

Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria

Grundman, M., Johnson, K. A., Lu, M., Siderowf, A. D., Dell’Agnello, G., Arora, A., Skovronsky, D., Mintun, M. A., Pontecorvo, M. J., & for the 18F-AV-45-A17 Study Group (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000441139 · Cited by 38

In Vivo Human Amyloid Imaging

Sojkova, J., & Resnick, S. M. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745375 · Cited by 36

Postmortem 3-D Brain Hemisphere Cortical Tau and Amyloid-β Pathology Mapping and Quantification as a Validation Method of Neuropathology Imaging

Šmid, L. M., Kepe, V., Vinters, H. V., Bresjanac, M., Toyokuni, T., Satyamurthy, N., Wong, K. P., Huang, S., Silverman, D. H. S., Miller, K. J., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122434 · Cited by 33

Amyloid Imaging in Alzheimer’s Disease and Other Dementias

Fodero‐Tavoletti, M. T., Cappai, R., McLean, C., Pike, K. E., Adlard, P. A., Cowie, T., Connor, A. R., Masters, C. L., Rowe, C. C., & Villemagne, V. L. (2009) · Brain Imaging and Behavior · doi:10.1007/s11682-009-9067-2 · Cited by 33

Biomarkers of Alzheimer’s Disease Risk in Peripheral Tissues; Focus on Buccal Cells

François, M., Leifert, W. R., Martins, R. N., Thomas, P., & Fenech, M. F. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140618103827 · Cited by 34

Usefulness of Brain Positron Emission Tomography with Different Tracers in the Evaluation of Patients with Idiopathic Normal Pressure Hydrocephalous

Mattoli, M. V., Treglia, G., Calcagni, M. L., Mangiola, A., Anile, C., & Trevisi, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186523 · Cited by 32

Radiopharmaceuticals for positron emission tomography investigations of Alzheimer’s disease

Någren, K., Halldin, C., & Rinne, J. O. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1301-z · Cited by 33

Comparison between amyloid-PET and CSF amyloid-β biomarkers in a clinical cohort with memory deficits

Bouter, C., Vogelgsang, J. S., & Wiltfang, J. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.02.005 · Cited by 32

Biomarkers in Alzheimer’s Disease

Riverol, M., & López, O. L. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00046 · Cited by 33

Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy

Mandel, S. A., Morelli, M., Halperin, I. J. Y., & Korczyn, A. D. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0036-z · Cited by 36

Amyloid Imaging in Early Detection of Alzheimer’s Disease

Nordberg, A. K. (2010) · Neurodegenerative Diseases · doi:10.1159/000289223 · Cited by 33

Amyloid PET Ligands for Dementia

Villemagne, V. L., & Rowe, C. C. (2010) · PET Clinics · doi:10.1016/j.cpet.2009.12.008 · Cited by 31

Alzheimer's Disease and the “Valley of Death”: Not Enough Guidance from Human Brain Tissue?

Beach, T. G. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129020 · Cited by 28

In Alzheimer's disease, amyloid beta accumulation is a protective mechanism that ultimately fails

Rischel, E. B., Gejl, M., Brock, B., Rungby, J., & GJEDDE, A. H. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12701 · Cited by 27

Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer’s Disease

Edmonds, E. C., Bangen, K. J., Delano‐Wood, L., Nation, D. A., Furst, A. J., Salmon, D. P., Bondi, M. W., & Initiative, A. D. N. (2016) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617716000928 · Cited by 28

Performance of 11C-Pittsburgh Compound B PET Binding Potential Images in the Detection of Amyloid Deposits on Equivocal Static Images

Hosokawa, C., Ishii, K., Kimura, Y., Hyodo, T., Hosono, M., Sakaguchi, K., Usami, K., Shimamoto, K., Yamazoe, Y., & Murakami, T. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.156414 · Cited by 26

Imaging Biomarkers in Alzheimer’s Disease: A Practical Guide for Clinicians

Sheikh‐Bahaei, N., Sajjadi, S. A., Manavaki, R., & Gillard, J. H. (2017) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170013 · Cited by 29

Identifying Cost-Effective Predictive Rules of Amyloid-β Level by Integrating Neuropsychological Tests and Plasma-Based Markers

Haghighi, M., Smith, A., Morgan, D., Small, B. J., Huang, S., & Initiative, A. D. N. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140705 · Cited by 25

FDDNP binding using MR derived cortical surface maps

Protas, H. D., Huang, S.-C., Kepe, V., Hayashi, K., Klunder, A. D., Braskie, M. N., Ercoli, L. M., Bookheimer, S. Y., Thompson, P. M., Small, G. W., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.08.035 · Cited by 24

Mapping brain β-amyloid

Jagust, W. J. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832d93c7 · Cited by 23

Diagnostic effectiveness of quantitative [18F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus

Leinonen, V., Rinne, J. O., Wong, D. F., Wolk, D. A., Trojanowski, J. Q., Sherwin, P. F., Smith, A. P. L., Heurling, K., Su, M., & Grachev, I. D. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-46 · Cited by 24

The Brain’s Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer’s Disease

Pandya, S., Initiative, A. D. N., Kuceyeski, A. F., & Raj, A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160090 · Cited by 24

Prospective Flutemetamol Positron Emission Tomography and Histopathology in Normal Pressure Hydrocephalus

Rinne, J. O., Frantzén, J., Leinonen, V., Lönnrot, K., Laakso, A., Virtanen, K. A., Solin, O. H., Kotkansalo, A., Koivisto, A. M., Sajanti, J., et al. (2013) · Neurodegenerative Diseases · doi:10.1159/000355256 · Cited by 21

Distinct spatiotemporal subtypes of amyloid deposition are associated with diverging disease profiles in cognitively normal and mild cognitive impairment individuals

Sun, Y., Zhao, Y., Hu, K., Wang, M., Liu, Y., Liu, B., & Initiative, A. D. N. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02328-2 · Cited by 24

γH2AX is increased in peripheral blood lymphocytes of Alzheimer’s disease patients in the South Australian Neurodegeneration, Nutrition and DNA Damage (SAND) study of aging

Siddiqui, M. S., Francois, M., Hecker, J., Faunt, J., Fenech, M. F., & Leifert, W. R. (2018) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2018.03.001 · Cited by 20

Synthesis and biological evaluation of novel radioiodinated imidazopyridine derivatives for amyloid-β imaging in Alzheimer’s disease

Chen, C.-J., Bando, K., Ashino, H., Taguchi, K., Shiraishi, H., Fujimoto, O., Kitamura, C., Matsushima, S., Fujinaga, M., Zhang, M., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.05.043 · Cited by 21

Cerebrospinal Fluid Biomarkers in iNPH: A Narrative Review

Pyrgelis, E.-S., Boufidou, F., Constantinides, V. C., Papaioannou, M. G., Papageorgiou, S. G., Stefanis, L., Paraskevas, G. P., & Kapaki, E. N. (2022) · Diagnostics · doi:10.3390/diagnostics12122976 · Cited by 19

Reduced CSF turnover and decreased ventricular Aβ42 levels are related

Sérot, J., Peltier, J., Fichten, A., Ledeme, N., Bourgeois, A.-M., Jouanny, P., Toussaint, P., Gars, D. L., Godefroy, O., & Mazière, J. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-42 · Cited by 20

Postmortem Pittsburgh Compound B (PiB) Binding Increases with Alzheimer's Disease Progression

Beckett, T. L., Webb, R. L., Niedowicz, D. M., Holler, C. J., Matveev, S., Baig, I., LeVine, H., Keller, J. N., & Murphy, M. P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120655 · Cited by 20

Voxel-Based Analysis of Amyloid-Burden Measured with [11C]PiB PET in a Double Transgenic Mouse Model of Alzheimer’s Disease

von Reutern, B., Grünecker, B., Yousefi, B. H., Henriksen, G., Czisch, M., & Drzezga, A. E. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0625-z · Cited by 17

Molecular Neuroimaging in Alzheimer's Disease

Matsuda, H., & Imabayashi, E. (2011) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2011.11.005 · Cited by 21

Advances in molecular imaging for the diagnosis of dementia

Okamura, N., Fodero‐Tavoletti, M. T., Kudo, Y., Rowe, C. C., Furumoto, S., Arai, H., Masters, C. L., Yanai, K., & Villemagne, V. L. (2009) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050903133790 · Cited by 18

Association of PET‐based stages of amyloid deposition with neuropathological markers of Aβ pathology

Teipel, S. J., Temp, A. G. M., Levin, F., Dyrba, M., Grothe, M. J., & Initiative, A. D. N. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51238 · Cited by 17

Distinct binding of amyloid imaging ligands to unique amyloid‐β deposited in the presubiculum of Alzheimer's disease

Ji, B., Chen, C.-J., Bando, K., Ashino, H., Shiraishi, H., Sano, H., Kasahara, H., Minamizawa, T., YAMADA, K., Ono, M., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13293 · Cited by 17

Enabling a multidisciplinary approach to the study of ageing and Alzheimer's disease: An update from the Australian Imaging Biomarkers and Lifestyle (AIBL) study

Ellis, K. A., Rainey‐Smith, S. R., Rembach, A., Macaulay, S. L., Villemagne, V. L., & Aibl research group (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.870136 · Cited by 17

11C-PiB PET ABri Imaging in Worster-Drought Syndrome (Familial British Dementia): A Case Report

Villemagne, V. L., Pike, K. E., Pejoska, S., Boyd, A., Power, M., Jones, G. R., Masters, C. L., & Rowe, C. C. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1241 · Cited by 17

Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus

Nakajima, M., Rauramaa, T. H., Mäkinen, P. M., Hiltunen, M. O., Herukka, S., Kokki, M., Musialowicz, T., Jyrkkänen, H. K., Danner, N., Junkkari, A., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14575 · Cited by 16

[ 11 C]PIB PET Is Associated with the Brain Biopsy Amyloid-β Load in Subjects Examined for Normal Pressure Hydrocephalus

Rinne, J. O., Suotunen, T., Rummukainen, J. K., Herukka, S., Nerg, O., Koivisto, A. M., Rauramaa, T. H., Någren, K., Hiltunen, M., Alafuzoff, I. I., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180645 · Cited by 16

Biomarkers for the clinical evaluation of the cognitively impaired elderly: amyloid is not enough

McEvoy, L. K., & Brewer, J. B. (2012) · Imaging in Medicine · doi:10.2217/iim.12.27 · Cited by 15

S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies

Leinonen, V., Rauramaa, T., Johansson, J., Bottelbergs, A., Tesseur, I., van der Ark, P. D., Pemberton, D., Koivisto, A., Jääskeläinen, J., Hiltunen, M., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180071 · Cited by 14

Palmomental Reflex a Relevant Sign in Early Alzheimer’s Disease Diagnosis?

Gabelle, A., Gutierrez, L., Dartigues, J., Ritchie, K. A., Touchon, J., & Berr, C. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150436 · Cited by 16

Biomarcadores en la enfermedad de Alzheimer

Ribas, G. G., López-Sendón, J. L., & Caldentey, J. G. (2014) · Revista de Neurología · doi:10.33588/rn.5807.2013394 · Cited by 14

Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer’s disease, subjects with amnestic mild cognitive impairment and healthy volunteers

Miki, T., Shimada, H., Kim, J., Yamamoto, Y., Sugino, M., Kowa, H., Heurling, K., Zanette, M., Sherwin, P. F., & Senda, M. (2017) · Annals of Nuclear Medicine · doi:10.1007/s12149-017-1154-7 · Cited by 15

The clinical safety, biodistribution and internal radiation dosimetry of flutemetamol (18F) injection in healthy Japanese adult volunteers

Senda, M., Brooks, D. J., Farrar, G., Somer, E. J., Paterson, C. L., Sasaki, M., & McParland, B. J. (2015) · Annals of Nuclear Medicine · doi:10.1007/s12149-015-0986-2 · Cited by 13

Parametric estimation of reference signal intensity in the quantification of amyloid-beta deposition: an 18F-AV-45 study

Initiative, T. A. D. N., Wang, M., Yan, Z., Zhang, H., Lu, J., Li, L., Yu, J., Wang, J., Matsuda, H., Zuo, C., et al. (2020) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-20-110 · Cited by 13

Clinical impact of 11 C ‐Pittsburgh compound‐ B positron emission tomography carried out in addition to magnetic resonance imaging and single‐photon emission computed tomography on the diagnosis of A lzheimer's disease in patients with dementia and mild cognitive impairment

Omachi, Y., Ito, K., Arima, K., Matsuda, H., Nakata, Y., Sakata, M., Sato, N., Nakagome, K., & Motohashi, N. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12326 · Cited by 13

Correlation of brain amyloid with “aerobic glycolysis”: a question of assumptions?

Phelps, M. E., & Barrio, J. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012684107 · Cited by 12

Update on the Cognitive Presentations of iNPH for Clinicians

Langheinrich, T., Chen, C., & Thomas, O. M. T. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.894617 · Cited by 11

Biopsy Support for the Validity of Pittsburgh Compound B Positron Emission Tomography With a Twist

Klunk, W. E. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1281 · Cited by 12

Prediction of cognitive decline based on hemispheric cortical surface maps of FDDNP PET

Protas, H. D., Kepe, V., Hayashi, K. M., Klunder, A. D., Braskie, M. N., Ercoli, L. M., Siddarth, P., Bookheimer, S. Y., Thompson, P. M., Small, G. W., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.02.056 · Cited by 11

Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases

Krishnadas, N., Doré, V., Laws, S. M., Porter, T., Lamb, F., Bozinovski, S., Villemagne, V. L., & Rowe, C. C. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12326 · Cited by 10

Clinical impact of 11C-Pittsburgh compound-B positron emission tomography in addition to magnetic resonance imaging and single-photon emission computed tomography on diagnosis of mild cognitive impairment to Alzheimer's disease

Kitajima, K., Abe, K., Takeda, M., Yoshikawa, H., Ohigashi, M., Osugi, K., Koyama, H., & Yamakado, K. (2021) · Medicine · doi:10.1097/md.0000000000023969 · Cited by 10

Applying the IWG Research Criteria in Clinical Practice

Molinuevo, J. L., & Rami, L. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.12.018 · Cited by 11

Amyloid Imaging

Jagust, W. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.152 · Cited by 10

The efficacy and limitation of lumboperitoneal shunt in normal pressure hydrocephalus

Liu, J.-T., & Su, P. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.105748 · Cited by 10

The value of FDG combined with PiB PET in the diagnosis of patients with cognitive impairment in a memory clinic

Liu, F., Shi, Y., Wu, Q., Chen, H., Wang, Y., Cai, L., & Zhang, N. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14418 · Cited by 9

Amyloid deposition in semantic dementia: a positron emission tomography study

Brown, E. E., Graff‐Guerrero, A., Houle, S., Mizrahi, R., Wilson, A. A., Pollock, B. G., Mulsant, B. H., Felsky, D., Voineskos, A. N., Tang‐Wai, D. F., et al. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4423 · Cited by 9

The correlation between striatal and cortical binding ratio of 11C-PiB-PET in amyloid-uptake-positive patients

Sauerbeck, J., Ishii, K., Hosokawa, C., Kaida, H., Scheiwein, F., Hanaoka, K., Rominger, A., Brendel, M., Bartenstein, P., & Murakami, T. (2018) · Annals of Nuclear Medicine · doi:10.1007/s12149-018-1258-8 · Cited by 8

The Use of Biomarkers for Prediction and Prevention of Alzheimer’s and Parkinson’s Diseases

Mandel, S. A., & Korczyn, A. D. (2012) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5866-7_6 · Cited by 6

The exception makes the rule

Ringman, J. M., Teplow, D. B., & Villemagne, V. L. (2012) · Neurology · doi:10.1212/wnl.0b013e31825fe11f · Cited by 6

Radiological biomarkers of idiopathic normal pressure hydrocephalus: new approaches for detecting concomitant Alzheimer's disease and predicting prognosis

Cai, H., Zou, Y., Gao, H., Huang, K., Liu, Y., Cheng, Y., Liu, Y., Zhou, L., Zhou, D., & Chen, Q. (2022) · Psychoradiology · doi:10.1093/psyrad/kkac019 · Cited by 5

Biomarker changes in suspected idiopathic normal-pressure hydrocephalus patients undergoing external lumbar drainage: a pilot study

Brgić, K., Mrak, G., Barić, H., Marasanov, S., Šimić, G., Španić, E., & Klarica, M. (2024) · Croatian Medical Journal · doi:10.3325/cmj.2024.65.328 · Cited by 5

PET and SPECT Imaging of Neurodegenerative Diseases

Drzezga, A. E., Bischof, G. N., Giehl, K., & van Eimeren, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00085-5 · Cited by 4

Neuroimaging of Alzheimer’s Disease, Mild Cognitive Impairment, and Other Dementias

Risacher, S. L., & Saykin, A. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6373-4_19 · Cited by 5

Aβ Imaging in Aging, Alzheimer’s Disease and Other Neurodegenerative Conditions

Villemagne, V. L., Fodero‐Tavoletti, M. T., Yates, P. A., Masters, C. L., & Rowe, C. C. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_10 · Cited by 4

Neuropathological Basis of Alzheimer’s Disease and Alzheimer’s Disease Diagnosis

Schneider, J. A., Montine, T. J., Sperling, R. A., & Bennett, D. A. (2012) · Advances in biological psychiatry · doi:10.1159/000335384 · Cited by 4

Atypical parkinsonism, parkinsonism-plus syndromes and secondary parkinsonian disorders

Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00009-3 · Cited by 2

Atypical parkinsonism, parkinsonism-plus syndromes, and secondary parkinsonian disorders

Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00009-3 · Cited by 2

Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral Amyloidoma

Groot, C., Tolboom, N., Ikonomović, M. D., Lammertsma, A. A., Boon, B. D. C., Barkhof, F., Scheltens, P., Klunk, W. E., Rozemüller, A. J. M., Ossenkoppele, R., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180316 · Cited by 2

Aβ Imaging in Aging, Alzheimer’s Disease, and Other Neurodegenerative Conditions

Villemagne, V. L., Doré, V., Burnham, S. C., & Rowe, C. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_10 · Cited by 2

Update Amyloid-Bildgebung in der Diagnostik der Neurodegeneration

Drzezga, A. E., & Giehl, K. (2022) · Angewandte Nuklearmedizin · doi:10.1055/a-1712-6110 · Cited by 1

Dementia Due to Neurodegenerative Disease: Molecular Imaging Findings

Ossenkoppele, R., Booij, J., Scheltens, P., & van Berckel, B. N. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_9 · Cited by 1

Translational Research in Alzheimer’s Disease for Development of Antibody-Based Therapeutics

Yuen, E., Liu, E., & Kinney, G. G. (2012) · Springer eBooks · doi:10.1007/978-1-4419-5955-3_14 · Cited by 1

In Vivo Imaging in Neurodegenerative Diseases

Wang, X., Arbel‐Ornath, M., Wegmann, S., Kastanenka, K. V., & Bacskai, B. J. (2014) · Springer eBooks · doi:10.1007/978-94-017-9361-2_3 · Cited by 1

Normal Pressure Hydrocephalus: Etiology, Diagnosis, Treatment, and Putative Nutritional and Lifestyle Risk Factors

McGirr, A., Vila-Rodriguez, F., & Cusimano, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00010-0 · Cited by 1

Negative 11C-PIB PET Predicts Lack of Alzheimer’s Disease Pathology in Postmortem Examination

Scheinin, N. M., Gardberg, M., Röyttä, M., & Rinne, J. O. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170569 · Cited by 1

The Role of Apolipoprotein E Concentration and Isoform in Amyloid-beta Metabolism In Vivo

Castellano, J. M. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7416v3s

Amyloid imaging in Alzheimer´s disease and mild cognitive impairment by Positron Emission Tomography

Forsberg, A. (2008) · Figshare

Enfermedad de Alzheimer de inicio presenil esporádica: Caracterización clínico-biológica y diagnóstico precoz

Balasa, M. (2013) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)

Degree of abnormality is associated with rate of change in measures of beta-amyloid, glucose metabolism and cognition in an autopsy-verified Alzheimer’s disease case

Almkvist, O., Kadir, A., & Nordberg, A. K. (2014) · Neurocase · doi:10.1080/13554794.2014.979835

Amyloidplaque-Bildgebung in der Demenzdiagnostik

Drzezga, A. E. (2009) · Der Nuklearmediziner · doi:10.1055/s-0028-1128137

Pittsburgh compound B as a marker of cognitive decline

Rinne, J. O. (2010) · Future Neurology · doi:10.2217/fnl.10.23

Pet Amyloid Imaging: Can Its Diagnostic Potential Be Effectively Realized in the clinic?

Fleisher, A., & Wolk, D. A. (2011) · Neurodegenerative Disease Management · doi:10.2217/nmt.11.73

Klinischer Nutzen nuklearmedizinischer Verfahren in der Demenzdiagnostik

Drzezga, A. E. (2009) · Nervenheilkunde · doi:10.1055/s-0038-1627142

E Deputy Editor: Dr J.A.J.M. Deckers E Editorial Board:

Aarnink, R., Beckett, J., Maniawski, P., Neitzel, U., Silfen, E., Zeitler, G., Zimmermann, W., & Highway, B. E. (2009)

Mild Cognitive Impairment and Early Detection of Alzheimer`s Disease. A Positron Emission Tomography Study

Koivunen, J. (2011) · UTUPub (University of Turku)

Early AD pathology in a (C-11)PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study Milos D. IkonomovicEric E. AbrahamsonJulie C. PriceRonald L. Hamilton • Chester A. MathisWilliam R. PaljugManik L. DebnathAnne D. Cohen • Katsuyoshi MizukamiSteven T. DeKoskyOscar L. LopezWilliam E. Klunk

Ikonomovic, M. D., Abrahamson, E. E., Paljug, W. R., Klunk, L. W. E., Debnath, M. L., Cohen, A. D., Klunk, W. E., Price, J. C., Mathis, C. A., Hamilton, R. L., et al. (2012)

Molecular imaging in dementia: journey to the end of the night

Villemagne, V. L. (2009)

VARIANCE OF THE AMYLOID BETA PEPTIDE AS A METRIC FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE

Beckett, C. (2016) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2016.161

Nuclear Imaging of Dementia

Drzezga, A. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-30081-8_26

Biomarkers in Mild Stages of Alzheimer’s disease: Utility in clinical practice and their relation with nutritional and lifestyle factors

Dillon, C., Leguizamon, P. P., Heisecke, S. L., Castro, D. M., López‐Camelo, J. S., Loñ, L., Serrano, C. M., Guelar, V., & Taragano, F. E. (2016) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v6i10.299

Imaging Amnestic Mild Cognitive Impairment: Neuroinflammation, Beta-amyloid and Glutathione

Knezevic, D. (2016) · TSpace (University of Toronto)

Idiopathic Normal Pressure Hydrocephalus : Focus on Imaging and Clinical Symptoms

Eleftheriou, A. (2025) · Linköping University medical dissertations · doi:10.3384/9789181180916

Elderly-onset iatrogenic cerebral amyloid angiopathy presenting with lobar and deep haemorrhages

Sakamoto, H., Murakami, A., Kono, Y., Nakamura, M., Higasa, K., & Yakushiji, Y. (2025) · BMJ Case Reports · doi:10.1136/bcr-2025-267435

P1‐369: Brain [11C]‐PIB uptake reflects beta‐amyloid burden detected by immunohistochemistry in frontal cortex biopsy specimens

Rinne, J. O. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.649

Early Detection of Alzheimer's Disease Beta-amyloid Pathology -Applicability of Positron Emission Tomography with the Amyloid Radioligand 11C-PIB

Scheinin, N. M. (2010) · UTUPub (University of Turku)

Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study

Ikonomović, M. D., Abrahamson, E. E., Price, J. C., Hamilton, R. L., Mathis, C. A., Paljug, W. R., Debnath, M. L., Cohen, A. D., Mizukami, K., DeKosky, S. T., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0943-2 · Cited by 87

Amyloid β Accumulation Assessed with 11C-Pittsburgh Compound B PET and Postmortem Neuropathology

Hatsuta, H., Takao, M., Ishii, K., Ishiwata, K., Saito, Y., Kanemaru, K., Arai, T., Suhara, T., Shimada, H., Shinotoh, H., et al. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150302155930 · Cited by 13

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496